Novo obesity drug could launch in U.S. end 2014
COPENHAGEN (Reuters) - Danish drug maker Novo Nordisk said it could launch obesity treatment liraglutide in the United States by the end of next year ...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/dytn1fj0li0/story01.htm
No comments:
Post a Comment